03:14 , Jun 9, 2017 |  BC Week In Review  |  Financial News

ONL Therapeutics raises $4.3M in series A

On May 17, ophthalmic company ONL Therapeutics Inc. (Ann Arbor, Mich.) raised $4.3 million in a series A round, including the conversion of a $1 million bridge loan. Investors included Novartis AG (NYSE:NVS; SIX:NOVN), University...
08:00 , Dec 24, 2007 |  BioCentury  |  Emerging Company Profile

Corporate Profile

ProNAi Therapeutics Inc. Kalamazoo, Mich. Technology: Single-stranded DNA interfering therapeutic agents Disease focus: Cancer Clinical status: Preclinical Founded: 2004 by Robert Forgey, Neal Goodwin, Don Parfet, Mina Sooch and Eli Thomssen University collaborators: Wayne State...